Table 1:

Patient and index aneurysm characteristics

CharacteristicsSurgical (n = 143)Endovascular (n = 148)
Patient
 Age at treatment (mean) (SD) (yr)56.1 (10)56.9 (10)
 Female sex (No.) (%)98 (69%)105 (71%)
Pretreatment mRS score (No.) (%)
 0120 (84)114 (77)
 122 (15)29 (20)
 21 (1)5 (3)
Patients with multiple aneurysms (No.) (%)26 (18)38 (26)
Index aneurysm location (No.) (%)
 Anterior circulation (No.) (%)139 (97)143 (97)
  ICA
   Ophthalmic/paraophthalmic17 (12)18 (12)
   Posterior communicating/anterior choroidal16 (11)29 (20)
   Carotid terminus13 (9)12 (8)
  MCA
   MCA bifurcation/M143 (30)48 (32)
  ACA
   Anterior communicating43 (30)31 (21)
   Pericallosal5 (3)5 (3)
   Other2 (1)0
Posterior circulation (No.) (%)4 (3)5 (3)
 PCA01 (1)
 SCA02 (1)
 PICA4 (3)2 (1)
Index aneurysm size (mean) (range) (mm)7.7 (3–20)7.9 (3–24)
 3–9 mm (%)112 (78)115 (78)
 10–15 mm (%)26 (18)28 (19)
 >15 mm (%)5 (3)5 (3)
Aneurysm neck ≥4 mm56 (39)56 (38)
Recurrent, previously treated index aneurysm7 (5)3 (2)
Medical history
 Pain/headache15 (10)19 (13)
 Cranial nerve palsy4 (3)4 (3)
 Stroke/TIA5 (3)3 (2)
 History of previous SAH from another aneurysm19 (13)18 (12)
 Hypertension73 (51)71 (48)
 Current smoker56 (39)62 (42)
 Excessive alcohol14 (10)9 (6)
 Positive family history27 (19)26 (18)
Treatment
 Time from randomization to treatment (mean) (SD) (wk)17.8 (22)9.4 (18)
 Adherence to assigned treatment (No.) (%)138 (97)142 (96)
 Index aneurysm rupture after randomization, before  treatment1 (1)0
 Additional nonindex aneurysms treated at same time14 (10)15 (10)
 Stent-assisted coiling (non-flow-diverting stent) (No.) (%)NA29 (19)
 Flow-diverting stent (No.) (%)NA9 (6)
  • Note:—NA indicates not applicable.